Case Study Investment Bank Sidesteps Deal After Decision Quality Analysis Uncovers Major Flaw in Potential Acquisition
Case Study Asset Portfolio Strategy for a Major Biotech Company Facilitates Launch of a Therapeutic to Treat a Serious Complication of Chemo
Case Study Customer Perspective Prompts Engineering Company to Expand R&D Effort Beyond Initial Product
Case Study SDG Helps Government Develop a Market-Based Policy Program for Economic Growth and Job Creation
Case Study New Process for Evaluating and Managing Investments Triples Return for Fortune 100 Company
Case Study Forward-Looking Planning Tool Allows Management to Anticipate—and Reverse—Inventory Buildup
Case Study Large City Faced with Resource Limitations Seeks Optimal Portfolio of Public Sector Projects
Case Study Collaborative Approach Among Operators Maximizes Value for the Canadian Oil Sands Industry
Case Study Joint Venture Grapples with Risk as it Seeks to Maximize the Value of a Mature Oil and Gas Asset
Case Study Major Oil & Gas Company Seeks Integrated Development Decision for Portfolio of Offshore Gas Fields
Case Study Amid Shifting Regulatory Environment, Upstream O&G JV is Open to Previously Unconsidered Strategies
Case Study Custom Dashboard Gives Government of Crude-Export Country Insight into Global Oil Market Indicators
Case Study Rapid, Transparent Evaluation Helps ‘Stuck’ Biotech Board Resolve Debate over Promising Cancer Therapy
Case Study Media and Entertainment Provider Harnesses Uncertainty about the Future to Decide Where to Place Bets
Case Study Renewable energy company finds new ways to evaluate disruptive technologies, speeding investment decisions
Case Study Cutting-edge Prioritization Model Enables Consistent Evaluation of Early-stage Drugs Across Pharma Portfolio
Case Study Business Plan Development for a Major Engineering Company Revealed Necessity to Expand R&D Effort to Several of the Company’s Products.
Case Study Novel, Forward-Looking Planning Tool Allows Management to Anticipate and Reverse Inventory Buildup
Case Study Pharmaceutical Company Requires Nimble Development Strategy When Faced with Unforeseen Challenges